Evidence map›Paper›PMID 36806247›Full record

ArticleThe Journal of veterinary medical science2023

Detection of anti-feline infectious peritonitis virus activity of a Chinese herb extract using geneLEAD VIII, a fully automated nucleic acid extraction/quantitative PCR testing system.

Rui Nishijima, Takuro Endo, Enkhjavkhlan Gankhuyag, Shwe Thiri Maung Maung Khin, Sheikhy Mohammad Jafar, Yuta Shinohara, Yoshikazu Tanaka, Kazumi Sawakami, Masafumi Yohda, Tetsuya Furuya

Open access · diamondAbstract read
In one paragraph

Article in The Journal of veterinary medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Rui NishijimaDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Takuro EndoLaboratory of Veterinary Infectious Diseases, Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Enkhjavkhlan GankhuyagDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Shwe Thiri Maung Maung KhinLaboratory of Veterinary Infectious Diseases, Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Sheikhy Mohammad JafarLaboratory of Veterinary Infectious Diseases, Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Yuta ShinoharaIskra Industry Co., Ltd., Tokyo, Japan.
Yoshikazu TanakaDepartment of Veterinary Hygiene, Veterinary School, Nippon Veterinary and Life Science University, Tokyo, Japan.
Kazumi SawakamiPrecision System Science Co., Ltd., Chiba, Japan.
Masafumi YohdaDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Tetsuya FuruyaLaboratory of Veterinary Infectious Diseases, Cooperative Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Tokyo University of Agriculture and Technology · JPNippon Veterinary and Life Science University · JPSumitomo Precision Products (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The geneLEAD VIII is a fully-automated nucleic acid extraction/quantitative PCR equipment developed by Precision System Science Co., Ltd., (PSS). To take advantage of its capability, we developed a quantitative assay system to measure growth of animal viruses. The system was used to assay one of the Chinese herbal extracts whose anti-malarial activities were previously reported and demonstrated its dose-dependent anti-viral activity against feline infectious peritonitis virus (FIPV), a feline coronavirus causing the fatal diseases in cats, and relatively low cell toxicity. The assay developed in this study is useful to screen antiviral drugs and the anti-FIPV activity of the herbal extract identified have a potential to lead to development of new drugs against FIPV and other coronaviruses, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Indexed as

Antineoplastic AgentsCat DiseasesCoronavirus, FelineCOVID-19PeritonitisAnimalsAntiviral AgentsCatsCOVID-19 TestingPolymerase Chain ReactionSARS-CoV-2Antineoplastic AgentsAntiviral Agentsassayautomated-qPCRChinese herbal extractdrugfeline infectious peritonitis virus

Identifiers

PMID36806247
PMCPMC10139796
OpenAlexW4321021547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.